Long non‐coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR‐363‐3p
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long non‐coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR‐363‐3p
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 11, Issue 3, Pages 659-671
Publisher
Wiley
Online
2020-01-23
DOI
10.1111/1759-7714.13310
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MDM2 promotes epithelial–mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma
- (2019) Yong Tang et al. OncoTargets and Therapy
- miR‐363‐3p inhibits migration, invasion, and epithelial–mesenchymal transition by targeting NEDD9 and SOX4 in non‐small‐cell lung cancer
- (2019) Jingxia Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer
- (2018) Joanna Bogusławska et al. CANCER LETTERS
- LncRNA XIST functions as a molecular sponge of miR-194-5p to regulate MAPK1 expression in hepatocellular carcinoma cell
- (2018) Qinglei Kong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-363-3p inhibits osteosarcoma cell proliferation and invasion via targeting SOX4
- (2018) Kejun Wang et al. ONCOLOGY RESEARCH
- Cell death-based treatment of lung adenocarcinoma
- (2018) Tatiana V. Denisenko et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway
- (2017) Wangwang Qiu et al. GENE
- LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR
- (2017) Wei Wei et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells
- (2017) Xin Tian et al. ONCOLOGY REPORTS
- Mechanistic insights in X-chromosome inactivation
- (2017) Zhipeng Lu et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer
- (2017) Dong-liang Chen et al. Cell Death & Disease
- MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4
- (2016) Fayong Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
- (2016) Subash Chandra Gupta et al. INTERNATIONAL JOURNAL OF CANCER
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- MDM2-p53 Pathway in Hepatocellular Carcinoma
- (2014) X. Meng et al. CANCER RESEARCH
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats
- (2014) De-Hui Zhang et al. Asian Pacific Journal of Tropical Medicine
- Long non-coding RNA: a new player in cancer
- (2013) Hua Zhang et al. Journal of Hematology & Oncology
- Regulation of mRNA Translation and Stability by microRNAs
- (2010) Marc Robert Fabian et al. Annual Review of Biochemistry
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- A Brief Review on the Mechanisms of miRNA Regulation
- (2010) Yimei Cai et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started